SCHEMBL7990920

SCHEMBL7990920

CC(C)(COc1ccc(Br)cn1)c1ccc(F)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.35
KDM4E B2RXH2 2/20 0.35
CXCR1 P25024 2/20 0.35
CXCR2 P25025 2/20 0.35
GRM2 Q14416 1/20 0.35
GABRA5 P31644 1/20 0.34
DGAT1 O75907 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
EPHX2 P34913 1/20 0.33
CYP2J2 P51589 1/20 0.33
HPGD P15428 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
HDAC3 O15379 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1403884 0.74 KDM4E (0.43) KDM4EGABRA5DGAT1L3MBTL1ALDH1A1
SCHEMBL2461154 0.74 L3MBTL1 (0.56) THRBKDM4EGABRA5L3MBTL1ALDH1A1
SCHEMBL1821132 0.73 GBA1 (0.40) THRBKDM4EGABRA5DGAT1L3MBTL1
SCHEMBL510047 0.73 MAOB (0.49) KDM4ECXCR2GABRA5CYP2C9CYP2C19
SCHEMBL12294290 0.72 ATM (0.43) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL17006857 0.72 ELOVL1 (0.57) KDM4EL3MBTL1ALDH1A1MEN1KMT2A
SCHEMBL18402510 0.71 KDM4E (0.38) THRBKDM4EGABRA5DGAT1L3MBTL1
SCHEMBL19229877 0.71 NUDT1 (0.43) KDM4ECXCR1CXCR2GABRA5L3MBTL1
SCHEMBL21038121 0.71 ELOVL1 (0.37) KDM4ECXCR1CXCR2L3MBTL1ALDH1A1
SCHEMBL24907185 0.70 ME2 (0.35) KDM4EHDAC3HDAC1HDAC2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6180650-B1 ANTIINFLAMMATORY AGENTS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTITUMOR AGENTS MERCK FROSST CANADA & CO. (CA) 2001-01-30 US disclosed